Please wait ...

Michael Mithoefer, MD


Michael Mithoefer, MD, clinical assistant professor of psychiatry at the Medical University of South Carolina. In 2009, he completed & published the first FDA approved clinical trial of MDMA assisted psychotherapy for treatment-resistant PTSD, followed by completion of a Phase II trial. He is overseeing a multisite Phase III study of MDMA-assisted psychotherapy in 13 sites around the US (including the Trauma Research Foundation), and another MDMA-assisted psychotherapy multisite study in Europe and Israel.

 

Speaker Disclosures:

Financial: Dr. Michael Mithoefer has employment relationships with the Medical University of South Carolina and the Multidisciplinary Association for Psychedelic Studies. He has an ownership interest in Awakn Life Sciences and serves on the scientific advisory board. Dr. Mithoefer receives a speaking honorarium and recording royalties from PESI, Inc.

Non-financial: Dr. Michael Mithoefer is a fellow of the American Psychiatric Association.

 

Psychedelics in Therapy: New Ways to Catalyze Healing


Faculty:
Michael Mithoefer, MD
Duration:
1 Hour 56 Minutes
Copyright:
Jan 12, 2021
Product Code:
NOS096105
Media Type:
Digital Seminar
Price:
$199.95 - Standard

Psychedelic-Assisted Therapy: Breakthrough Treatments for Complex Mental Health Disorders


Faculty:
Peter H Addy, PhD, LPC, LMHC |  Michael Mithoefer, MD |  Gabor Maté, MD |  Janis Phelps, PhD
Duration:
15 Hours 8 Minutes
Product Code:
CRS001482
Media Type:
Online Course
Price:
$158.99 Standard - $609.95

Showing 1 to 2 of 2 entries